Vencorex presents its long term strategic ambition. This strategy is based on focusing its activities toward specialty isocyanates. (HDI, IPDI, derivatives and new products).
Vencorex objective is to strengthen its worldwide position in Aliphatic Isocyanates business. (HDI, IPDI, Tolonate & Easaqua grades and new products).
To achieve this long term ambition, Vencorex plans to enhance its footprint on production capabilities, commercial activities and R&D innovation towards the following configuration.
Tolonate production facilities in 3 main continents ready to serve global market. Vencorex already has these at Pont De Claix, France and Freeport, TX USA, with an additional facility being implemented in Thailand, starting in 2015.
With all these initiatives, Vencorex will therefore implement several industrial projects with the objective to sustain its position as among the leading global partners for specialty isocyanates in the coming years.
Vencorex strategic ambition is supported by both shareholders: PTTGC and Perstorp.
本站所有信息與內(nèi)容,版權(quán)歸原作者所有。網(wǎng)站中部分新聞、文章來源于網(wǎng)絡(luò)或會(huì)員供稿,如讀者對(duì)作品版權(quán)有疑議,請(qǐng)及時(shí)與我們聯(lián)系,電話:025-85303363 QQ:2402955403。文章僅代表作者本人的觀點(diǎn),與本網(wǎng)站立場(chǎng)無關(guān)。轉(zhuǎn)載本站的內(nèi)容,請(qǐng)務(wù)必注明"來源:林中祥膠粘劑技術(shù)信息網(wǎng)(www.423344.com)".
更多
©2015 南京愛德福信息科技有限公司 蘇ICP備10201337 | 技術(shù)支持:南京聯(lián)眾網(wǎng)絡(luò)科技有限公司